Related Experiment Video
Updated: May 29, 2025

Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
The Vitamin D-Sirt1/PGC1α Axis Regulates Bone Metabolism and Counteracts Osteoporosis
Cuicui Yang1, Lulu Chen1, Xiaoli Guo1
1The Research Center for Bone and Stem Cells, Department of Anatomy, Histology and Embryology, Nanjing Medical University, Nanjing, China.
Background:
Objective: Vitamin D insufficiency is a major contributor to osteoporosis. This study aimed to elucidate the mechanisms by which the vitamin D-Sirt1/PGC1α axis regulates bone metabolism and counteracts osteoporosis induced by active vitamin D insufficiency.
Methods:
Mouse models including Sirt1 transgenic (Sirt1Tg), Cyp27b1+/- (active vitamin D deficient), and compound Sirt1TgCyp27b1+/- mice were utilized. Bone parameters were assessed by radiography, micro-CT, histology, and immunohistochemistry. In vitro studies used bone marrow-derived mesenchymal stem cells (BM-MSCs). Gene and protein expression were analyzed by RT-PCR and Western blotting. Chromatin immunoprecipitation and luciferase assays investigated transcriptional regulation. Effects of resveratrol supplementation were examined.
Results:
1,25-dihydroxyvitamin D (1,25(OH)2D) insufficiency caused downregulation of Sirt1 expression, leading to accelerated bone loss. Overexpression of Sirt1 in mesenchymal stem cells corrected bone loss by inhibiting oxidative stress, DNA damage, osteocyte senescence and senescence-associated secretory phenotype, promoting osteoblastic bone formation, and reducing osteoclastic bone resorption. 1,25(OH)2D3 transcriptionally upregulated Sirt1 expression in BM-MSCs through vitamin D receptor binding to the Sirt1 gene promoter. Resveratrol, a Sirt1 agonist, attenuated osteoporosis induced by 1,25(OH)2D insufficiency by modulating the Sirt1/PGC1α axis. Sirt1 interacted with and deacetylated PGC1α, a transcriptional coactivator involved in mitochondrial biogenesis and energy metabolism. Deacetylated PGC1α mediated the effects of Sirt1 on osteogenesis, oxidative stress, and cellular senescence in BM-MSCs.
Conclusion:
This study elucidated the critical role of the vitamin D-Sirt1/PGC1α axis in regulating bone metabolism and counteracting osteoporosis induced by active vitamin D insufficiency. The findings highlight the potential of this axis as a therapeutic target for the prevention and treatment of osteoporosis.
Insights
Vitamin D deficiency accelerates bone loss by reducing Sirt1. Restoring Sirt1, via the vitamin D-Sirt1/PGC1α axis, combats osteoporosis by improving bone formation and reducing resorption.
Area of Science:
- Endocrinology
- Bone Biology
- Molecular Biology
Background:
- Vitamin D insufficiency is a primary driver of osteoporosis.
- The vitamin D-Sirt1/PGC1α axis's role in bone metabolism requires elucidation.
- Understanding these mechanisms can reveal new osteoporosis treatments.
Purpose of the Study:
- To investigate how the vitamin D-Sirt1/PGC1α axis regulates bone metabolism.
- To determine the axis's role in counteracting osteoporosis caused by vitamin D insufficiency.
Main Methods:
- Utilized Sirt1 transgenic and vitamin D-deficient mouse models.
- Assessed bone parameters via radiography, micro-CT, and histology.
- Employed in vitro studies with bone marrow-derived mesenchymal stem cells (BM-MSCs) and molecular analyses.
Main Results:
- Vitamin D insufficiency decreased Sirt1, accelerating bone loss.
- Sirt1 overexpression in BM-MSCs reversed bone loss, reducing senescence and promoting osteogenesis.
- Vitamin D upregulated Sirt1 transcriptionally; resveratrol mimicked these effects via the Sirt1/PGC1α axis.
Conclusions:
- The vitamin D-Sirt1/PGC1α axis is crucial for bone metabolism and preventing osteoporosis.
- Targeting this axis offers a potential therapeutic strategy for osteoporosis.
More Related Videos
Related Concept Videos
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Skeleton and Calcium Homeostasis
Osteoclasts in Bone Remodeling

